Bipolar disorder Healthcare Pharmaceuticals 
Mad in America
FEBRUARY 20, 2024
What’s concerning is that despite the significant impact of sexual dysfunction on patients’ quality of life, many did not discuss these issues with their healthcare providers. Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine.
Mad in America
NOVEMBER 7, 2023
The clinician might regard some treatment options as ill-suited to that particular patient: ketamine, for example, in a patient with bipolar disorder (because research has only just recently been expanded to include bipolar depression). One of the reasons: creating informative Patient Decision Aids (PDAs) is difficult.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JANUARY 9, 2024
This article explains what assays are, how they entered healthcare and the consequences of failing to grasp the role they play. Those who see healthcare going down the tubes get indignant about these adverts, saying all would be fine if there were no free lunches and doctors were guided by the evidence. They go by the evidence.
Mad in America
JANUARY 9, 2025
S ince the 1990s, weve been hearing about the amazing progress in mental healthcare: We learned that mental illnesses like depression are serious but treatable diseases. But now they often say Since they have bipolar disorder, theyll never be able to manage their emotions or achieve any stability. This explains why the U.S.
Mad in America
OCTOBER 10, 2023
With the explosion of more and more drugs in cabinets across the country, more and more children are dying—but still, pharmaceutical companies push their products, leading to yet more drugs and yet more deaths. Unlike the pharmaceutical industry, in our village community the pain of losing a single child was felt by all.
Expert insights. Personalized for you.
141 
Let's personalize your content